Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Systematic Review

Published on 10 Oct 2025

Effects of non-invasive brain stimulation on balance control in patients with multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Longtao Zhang
Yanxiao Sun
Zhihao Diao
Yifan Jiang
Yufei Hu
Yuxia Ma

Frontiers in Neurology

doi 10.3389/fneur.2025.1696343

737 views

Original Research

Published on 09 Oct 2025

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study

in Multiple Sclerosis and Neuroimmunology

Gytis Makarevičius
Rasa Kizlaitienė
Gintaras Kaubrys
Nataša Giedraitienė

Frontiers in Neurology

doi 10.3389/fneur.2025.1635618

816 views

Systematic Review

Published on 07 Oct 2025

Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis

in Multiple Sclerosis and Neuroimmunology

Zhuyuan Fan
Dan Liu
Guangwei Zhang
Xinlin Guo

Frontiers in Neurology

doi 10.3389/fneur.2025.1649429

806 views

Systematic Review

Accepted on 06 Oct 2025

Effectiveness of respiratory muscle training in adults with multiple sclerosis: A systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Xiang Yuping
TANG OUFENG
ling zeng

Frontiers in Neurology

doi 10.3389/fneur.2025.1665651

Original Research

Published on 02 Oct 2025

The frequency of psoriasis in Australian multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Varitsara Mangkorntongsakul
Ariadna Fontes-Villalba
Turlough Montague
Olivia Charlton
Chun-Ting Justin Kwong
Helen Marie McGuire
Venkatesha Venkatesha
Geoffrey Herkes
Saxon Smith
John Parratt

Frontiers in Neurology

doi 10.3389/fneur.2025.1663015

1,192 views

Original Research

Accepted on 01 Oct 2025

A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany

in Multiple Sclerosis and Neuroimmunology

Achim Berthele
Clemens Gödel
Boris-Alexander Kallmann
Markus Christian Kowarik
Klaus Lehmann-Horn
Martin Marziniak
Sebastian Rauer
Veit Rothhammer
Florian Then Bergh
Mathias Wahl

Frontiers in Neurology

doi 10.3389/fneur.2025.1674742

177 views

Opinion

Accepted on 30 Sep 2025

Dyadic sleep in people with multiple sclerosis and their partners: Current research and future directions

in Multiple Sclerosis and Neuroimmunology

Anna Zanotto
Catherine F Siengsukon

Frontiers in Neurology

doi 10.3389/fneur.2025.1682411

273 views

Original Research

Accepted on 30 Sep 2025

Does C1 Esterase Inhibitor Play a Role in Post COVID-19 Neurological Symptoms? A Randomized, Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study

in Multiple Sclerosis and Neuroimmunology

Isaac R. Melamed
Caley Buckley
Mary Ellen Bayko
Joe Lynn Williams
Noga Orr (Or-Geva), PhD

Frontiers in Neurology

doi 10.3389/fneur.2025.1523814

161 views

Editorial

Published on 30 Sep 2025

Editorial: Women in multiple sclerosis and neuroimmunology: from bench to bedside

in Multiple Sclerosis and Neuroimmunology

Jessy J. Alexander
Krista D. DiSano
Liliana Patrucco
Mireya Fernandez-Fournier

Frontiers in Neurology

doi 10.3389/fneur.2025.1677618

1,004 views

Original Research

Published on 30 Sep 2025

Evaluating the impact of task-sequencing on cognitive and motor performance in MS: PASAT and 3-minute walk test order effects

in Multiple Sclerosis and Neuroimmunology

Valentin Siegert
Laura J. Köhler
Lucas Schreff
Daniel Hamacher
Patrick Oschmann
Veit Rothhammer
Philipp M. Keune
Roy Müller

Frontiers in Neurology

doi 10.3389/fneur.2025.1654656

762 views

Review

Accepted on 29 Sep 2025

Treatment and Prognosis of Failure of First-Line Immunotherapy or Recurrent Autoimmune Encephalitis Patients with Ofatumumab—a fully human anti-CD20 mAb

in Multiple Sclerosis and Neuroimmunology

Yajing Liu
Zhang Yanbo
Zhijiao Song
Shuanghao Feng
Tongxin Cao
Hui Bu

Frontiers in Neurology

doi 10.3389/fneur.2025.1671481

211 views

Policy and Practice Reviews

Published on 29 Sep 2025

Glial fibrillary acidic protein autoimmunity in reversible splenial lesion syndrome: diagnostic and therapeutic implications

in Multiple Sclerosis and Neuroimmunology

Lingling Lin
Xiang Li
Chao Quan
Jingzi Zhangbao
Hongmei Tan
Yi Wang
Siyuan Xu
Zhihao Dai

Frontiers in Neurology

doi 10.3389/fneur.2025.1650256

1,472 views

Original Research

Published on 29 Sep 2025

From demyelination to neurodegeneration in multiple sclerosis: reassessing the role of visual evoked potential P100-N145 amplitudes: a missing piece of the puzzle?

in Multiple Sclerosis and Neuroimmunology

Nurhan Kaya Tutar
Nilufer Kale

Frontiers in Neurology

doi 10.3389/fneur.2025.1649998

1,056 views

Hypothesis and Theory

Published on 25 Sep 2025

System-level hypothesis of dopamine imbalance in early multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Daniele Caligiore
Aurelia Schirripa
Monica Biggio

Frontiers in Neurology

doi 10.3389/fneur.2025.1653134

1,287 views

Original Research

Accepted on 23 Sep 2025

Familial frequency of psoriasis in patients with multiple sclerosis – results from an Australian survey

in Multiple Sclerosis and Neuroimmunology

Varitsara Mangkorntongsakul
Ariadna Fontes-Villalba
Chun-Ting Justin Kwong
Olivia Charlton
Helen Marie McGuire
Turlough Montague
Kevin Phan
Venkatesha Venkatesha
Geoffrey Herkes
Saxon Smith

Frontiers in Neurology

doi 10.3389/fneur.2025.1663031

612 views

Brief Research Report

Published on 22 Sep 2025

Peripheral neuromodulation in spasticity-plus syndrome: effects of pulsed radiofrequency on tonic-painful disorders in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Luigi Di Lorenzo
Carmine D’Avanzo

Frontiers in Neurology

doi 10.3389/fneur.2025.1634960

1,157 views